Medy-Tox Inc (KQ:086900) — Stock Price

₩80900.00 KRW
▲ 1.38% today

Medy-Tox Inc (KQ:086900) is currently trading at ₩80900.00 KRW, up 1.38% today. Over the past 52 weeks, shares have ranged between ₩68200.00 and ₩138600.00. This page tracks Medy-Tox Inc's live share price on the KQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Medy-Tox Inc worth.

Medy-Tox Inc (086900) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Medy-Tox Inc's daily closing share price and trading volume on the KQ exchange over the past year, giving a clear view of recent price momentum and liquidity.

Medy-Tox Inc Income Statement — Revenue, Profit & Earnings by Year

Medy-Tox Inc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue ₩228.62 Billion ₩221.12 Billion ₩195.10 Billion ₩184.87 Billion ₩140.83 Billion
Cost of Revenue ₩89.59 Billion ₩87.25 Billion ₩68.69 Billion ₩79.02 Billion ₩66.49 Billion
Gross Profit ₩139.03 Billion ₩133.87 Billion ₩126.41 Billion ₩105.85 Billion ₩74.34 Billion
Research & Development ₩29.82 Billion ₩25.13 Billion ₩23.32 Billion ₩23.27 Billion ₩32.54 Billion
SG&A ₩85.05 Billion ₩88.85 Billion ₩54.15 Billion ₩44.70 Billion ₩75.81 Billion
Total Operating Expenses ₩208.27 Billion ₩203.80 Billion ₩148.43 Billion ₩150.38 Billion ₩177.90 Billion
Operating Income ₩18.82 Billion ₩24.26 Billion ₩40.85 Billion ₩130.35 Billion ₩-41.45 Billion
EBITDA — — — — —
EBIT — — ₩46.67 Billion ₩33.14 Billion ₩-37.07 Billion
Interest Expense ₩1.73 Billion ₩2.33 Billion ₩2.31 Billion ₩4.78 Billion ₩4.18 Billion
Income Before Tax ₩17.50 Billion ₩15.85 Billion ₩49.53 Billion ₩128.27 Billion ₩-42.14 Billion
Income Tax Expense — — ₩12.93 Billion ₩35.00 Billion ₩-12.10 Billion
Net Income ₩16.95 Billion ₩9.76 Billion ₩37.01 Billion ₩94.15 Billion ₩-29.58 Billion

Medy-Tox Inc Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Medy-Tox Inc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets ₩615.16 Billion ₩611.62 Billion ₩596.29 Billion ₩577.70 Billion ₩467.76 Billion
Total Current Assets ₩186.57 Billion ₩166.23 Billion ₩135.13 Billion ₩160.96 Billion ₩138.71 Billion
Cash & Equivalents ₩45.65 Billion ₩33.17 Billion ₩20.67 Billion ₩71.77 Billion ₩43.99 Billion
Short-term Investments ₩13.35 Billion ₩98.91 Million ₩5.52 Billion ₩10.15 Billion ₩11.62 Billion
Net Receivables ₩53.88 Billion ₩60.51 Billion ₩45.00 Billion ₩28.70 Billion ₩34.16 Billion
Inventory ₩64.26 Billion ₩59.62 Billion ₩52.62 Billion ₩32.97 Billion ₩37.55 Billion
Property, Plant & Equipment ₩200.27 Billion ₩205.26 Billion ₩208.88 Billion ₩205.53 Billion ₩214.01 Billion
Goodwill ₩8.14 Billion ₩0.00 ₩0.00 ₩808.49 Million ₩0.00
Total Liabilities ₩144.38 Billion ₩137.14 Billion ₩168.24 Billion ₩178.22 Billion ₩226.37 Billion
Total Current Liabilities ₩117.55 Billion ₩126.56 Billion ₩135.26 Billion ₩107.95 Billion ₩117.59 Billion
Long-term Debt ₩20.00 Billion ₩0.00 ₩20.00 Billion ₩55.06 Billion ₩65.26 Billion
Net Debt ₩33.14 Billion ₩47.83 Billion ₩99.43 Billion ₩60.24 Billion ₩102.55 Billion
Total Stockholder Equity ₩466.48 Billion ₩469.46 Billion ₩428.04 Billion ₩399.48 Billion ₩241.40 Billion
Retained Earnings ₩425.21 Billion ₩406.66 Billion ₩401.11 Billion ₩364.11 Billion ₩268.15 Billion

Medy-Tox Inc Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Medy-Tox Inc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow ₩36.89 Billion ₩13.52 Billion ₩26.20 Billion ₩19.97 Billion ₩27.93 Billion
Capital Expenditures ₩18.72 Billion ₩37.47 Billion ₩9.90 Billion ₩17.51 Billion ₩41.14 Billion
Free Cash Flow ₩17.83 Billion ₩-23.95 Billion ₩1.10 Billion ₩-1.38 Billion ₩-16.38 Billion
Investing Cash Flow ₩-646.92 Million ₩13.25 Billion ₩-36.12 Billion ₩-27.78 Billion ₩-52.02 Billion
Financing Cash Flow ₩-24.05 Billion ₩-13.54 Billion ₩-40.39 Billion ₩34.80 Billion ₩50.72 Billion
Dividends Paid ₩8.42 Billion ₩8.42 Billion ₩8.04 Billion ₩8.04 Billion ₩5.54 Billion
Stock-Based Compensation ₩-552.97 Million ₩1.83 Billion ₩1.81 Billion ₩3.90 Billion ₩4.12 Billion
Depreciation ₩16.26 Billion ₩15.38 Billion ₩15.10 Billion ₩18.26 Billion ₩18.60 Billion
Change in Cash ₩12.92 Billion ₩12.56 Billion ₩-51.09 Billion ₩27.78 Billion ₩23.98 Billion

Medy-Tox Inc Earnings History — EPS Actual vs. Analyst Estimates

Track Medy-Tox Inc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 11, 2026 — — —
Nov 10, 2025 1059.01 — —
Aug 07, 2025 1192.83 — —
May 12, 2025 542.12 — —
Mar 05, 2025 451.35 — —
Nov 06, 2024 565.99 — —
Aug 09, 2024 1695.08 2058.00 -17.63%
May 10, 2024 -218.32 2255.00 -109.68%